- Home
- MODV vs CRVO Comparison
MODV vs CRVO Comparison
Compare MODV & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- CRVO
- Stock Information
- Founded
- MODV 1996
- CRVO 2001
- Country
- MODV United States
- CRVO United States
- Employees
- MODV N/A
- CRVO N/A
- Industry
- MODV Transportation Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- CRVO Health Care
- Exchange
- MODV Nasdaq
- CRVO Nasdaq
- Market Cap
- MODV 81.8M
- CRVO 95.4M
- IPO Year
- MODV N/A
- CRVO N/A
- Fundamental
- Price
- MODV $1.40
- CRVO $9.48
- Analyst Decision
- MODV Buy
- CRVO Strong Buy
- Analyst Count
- MODV 4
- CRVO 8
- Target Price
- MODV $8.38
- CRVO $25.43
- AVG Volume (30 Days)
- MODV 545.7K
- CRVO 13.7M
- Earning Date
- MODV 03-06-2025
- CRVO 03-17-2025
- Dividend Yield
- MODV N/A
- CRVO N/A
- EPS Growth
- MODV N/A
- CRVO N/A
- EPS
- MODV N/A
- CRVO N/A
- Revenue
- MODV $2,787,586,000.00
- CRVO $9,737,974.00
- Revenue This Year
- MODV $4.79
- CRVO N/A
- Revenue Next Year
- MODV $6.98
- CRVO N/A
- P/E Ratio
- MODV N/A
- CRVO N/A
- Revenue Growth
- MODV 1.32
- CRVO 36.29
- 52 Week Low
- MODV $1.38
- CRVO $1.80
- 52 Week High
- MODV $32.82
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- MODV 23.16
- CRVO 61.07
- Support Level
- MODV $1.68
- CRVO $7.13
- Resistance Level
- MODV $2.26
- CRVO $10.72
- Average True Range (ATR)
- MODV 0.29
- CRVO 2.50
- MACD
- MODV 0.04
- CRVO 0.07
- Stochastic Oscillator
- MODV 1.13
- CRVO 50.33
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.